Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan Triple Therapy vs Bismuth Quadruple Therapy for H. Pylori
NCT05726734Phase 4Not yet recruiting
- Sponsor
- Shanghai East Hospital
- Start
- Feb 2023
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vonoprazan in Helicobacter pylori infection, sponsored by Shanghai East Hospital. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05726734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05726734.